IBRX
ImmunityBio, Inc. Common Stock
$2.15
-0.93%
-0.02
Notify me if price changes either direction
Buy IBRX stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
2.1B
Enterprise value
2.7B
Trailing PE
-3.6271188218715
Forward PE
-3.3809526
PEG Ratio
0.07254237643743
Enterprise to EBITDA
-11.032
Enterprise to revenue
32.734
Price to book MRQ
-3.3357650994045
Price to sales TTM
25.413069
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-06-30
Revenue (TTM)
82.6M
EBITDA
-244947008
Diluted EPS TTM
-0.41
Total Cash (MRQ)
257.8M
Current ratio (MRQ)
5.767
Operating Cash Flow (TTM)
-319702016
IBRX trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
November 2025
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
